Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03474744
Title Copanlisib and Rituximab in Marginal Zone Lymphoma Patients
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Christian Buske
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU | AUT


No variant requirements are available.